Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity

Abstract

We aimed to evaluate the effects of exogenous intermittent teriparatide (rhPTH 1–34) administration versus the chronic exposure to excess endogenous parathyroid hormone (PTH), as in pHPT, on glucose homeostasis. Two patient groups were studied: Group 1 included 25 normocalcemic women with postmenopausal osteoporosis (age 65.2±1.6 years) studied before and six months after teriparatide initiation; Group 2 included 19 postmenopausal women with pHPT (age 55.2±2.5 years) studied before and six months after successful parathyroidectomy. Calcium – total (Ca) and corrected (CCa) – ALP, PTH, as well as glucose and insulin concentrations during an oral glucose tolerance test (OGTT) were determined before and six months after either intervention. Area under the curve for glucose (AUCglu) and insulin (AUCins) were calculated. ΔIns30′/ΔGlu30′ was applied as an index of insulin secretion. The HOmeostasis Model of Assessment (HOMA) and Matsuda ISI (Insulin Sensitivity Index) were used to calculate insulin resistance (IR) and whole body insulin sensitivity, respectively. In Group 1 no difference was found in any OGTT-derived parameter. In Group 2 significant reductions in AUCins and ΔIns30′/ΔGlu30′ were observed. No correlation between the change in ΔCCa or ΔPTH and ΔAUCglu or ΔAUCins was found in either group. Our data suggest that while subtle transient alterations of Ca and PTH within the normal range as in exogenous rhPTH 1-34 administration do not affect glucose homeostasis, the continuously elevated Ca and endogenous PTH levels as in pHPT affect insulin sensitivity and result in increased insulin secretion.

primary hyperparathyroidism - parathyroid hormone - teriparatide - glucose homeostasis - insulin sensitivity

References

• 1 Mak RH, Bettinelli A, Turner C, Haycock GB, Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia.  J Clin Endocrinol Metab. 1985;  60 229-233
• 2 Saxe AW, Gibson G, Gingerich RL, Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization.  Calcif Tissue Int. 1995;  57 127-132
• 3 Richards ML, Thompson NW. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy?.  Surgery. 1999;  126 1160-1166
• 4 Chiu KC, Chuang LM, Lee NP. et al . Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level.  Metabolism. 2000;  49 1501-1505
• 5 Taylor WH, Khaleeli AA. Coincident diabetes mellitus and primary hyperparathyroidism.  Diabetes Metab Res Rev. 2001;  17 175-180
• 6 Procopio M, Magro G, Cesario F. et al . The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism.  Diabet Med. 2002;  19 958-961
• 7 Procopio M, Borretta G. Derangement of glucose metabolism in hyperparathyroidism.  J Endocrinol Invest. 2003;  26 1136-1142
• 8 Khaleeli A, Johnson J, Taylor W. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.  Diabetes Metab Res Rev. 2007;  23 43-48
• 9 Wareham N, Byrne C, Carr C. et al . Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality.  Metabolism. 1997;  46 1171-1177
• 10 Wermers R, Khosla S, Atkinson E. et al . The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992.  Ann Intern Med. 1997;  126 433-440
• 11 MacCallum R, Parameswaran V, Burgess J. Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.  Clin Endocrinol (Oxf). 2006;  65 163-168
• 12 Fallo F, Cella G, Casonato A. et al . Biochemical markers of endothelial activation in primary hyperparathyroidism.  Horm Metab Res. 2006;  38 125-129
• 13 Valdemarsson S, Lindblom P, Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment.  J Intern Med. 1998;  244 241-249
• 14 Kovacs L, Goth M, Szabolcs I. et al . The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism.  Eur J Endocrinol. 1998;  138 543-547
• 15 Quin J, Gumpert J. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma.  Diabet Med. 1997;  14 80-81
• 16 Hagstrom E, Lundgren E, Rastad J, Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.  Eur J Endocrinol. 2006;  155 33-39
• 17 Gunal A, Celiker H, Celebi H, Ustundag B, Gunal S. Intravenous alfacalcidol improves insulin resistance in hemodialysis patients.  Clin Nephrol. 1997;  48 109-113
• 18 Kautzky-Willer A, Pacini G, Barnas U. et al . Intravenous calcitriol normalizes insulin sensitivity in uremic patients.  Kidney Int. 1995;  47 200-206
• 19 Lu K, Shieh S, Lin S. et al . Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.  Q J Med. 1994;  87 359-365
• 20 Fadda GZ, Akmal M, Lipson LG, Massry SG. Direct effect of parathyroid hormone on insulin secretion from pancreatic islets.  Am J Physiol. 1990;  258 975-984
• 21 Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul D, Guvener Demirag N. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.  J Clin Endocrinol Metab. 2006;  91 4260-4263
• 22 Anastasilakis A, Goulis D, Koukoulis G. et al . Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis.  Exp Clin Endocrinol Diabetes. 2007;  115 108-111
• 23 Phillips D, Clark P, Hales C, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.  Diabetic Med. 1994;  11 286-292
• 24 Wareham N, Phillips D, Byrne C, Hales C. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion.  Diabet Med. 1995;  12 931
• 25 Thomas DM, Rogers SD, Sleeman MW. et al . Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line.  J Mol Endocrinol. 1995;  14 263-275
• 26 Zablocki K, Michalik M, Bryla J. Substrate-dependent effect of 1-34 human parathyroid hormone fragment, dibutyryl cAMP and cAMP on gluconeogenesis in rabbit renal tubules.  Biochim Biophys Acta. 1986;  886 483-490
• 27 Kumar S, Olukoga AO, Gordon C. et al . Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism.  Clin Endocrinol (Oxf). 1994;  40 47-53
• 28 Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A. Urate and arteriosclerosis in primary hyperparathyroidism.  Clin Endocrinol (Oxf). 2001;  54 805-811
• 29 Fliser D, Franek E, Fode P. et al . Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans.  Nephrol Dial Transplant. 1997;  12 933-938
• 30 Yamaguchi T, Sugimoto T. Calcium homeostasis and diabetes mellitus.  Clin Calcium. 2006;  16 10-15
• 31 Nowicki M, Fliser D, Fode P, Ritz E. Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions.  J Clin Endocrinol Metab. 1996;  81 156-159
• 32 Prager R, Schernthaner G, Kovarik J. et al . Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance.  Calcif Tissue Int. 1984;  36 253-258
• 33 Prager R, Kovarik J, Schernthaner G, Woloszczuk W, Willvonseder R. Peripheral insulin resistance in primary hyperparathyroidism.  Metabolism. 1983;  32 800-805
• 34 MacCarty M, Thomas C. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight.  Med Hypotheses. 2003;  61 535-542
• 35 Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.  Diabetes Care. 1999;  22 1462-1470

Correspondence